Концептуальные и методологические аспекты исследования качества жизни в онкогематологии
Диссертация
Необходимость исследования качества жизни у больных со злокачественными заболеваниями системы крови закреплена в ряде документов-. которыми руководствуется" международное: сообщество: Согласно рекомендациям Food and Drug Administration (FDA, США, 1985 г.) оценку качества жизни больного следует включать в. клинические исследования, связанные с внедрением новых лекарственных препаратов… Читать ещё >
Список литературы
- Аронов Д.М., Зайцев В. П. Методика оценки качества жизни больных с сердечно-сосудистыми заболеваниями. Кардиология —2002— 5: 9295.
- Борисов А. И., Борисова А. А. О контроле качества медицинской помощи. Здравоохранение Российской Федерации. 1997- 3: 20—21.
- Всемирная организация здравоохранения. Обезболивание при раке. С описанием системы обеспечения больных опиоидными препаратами. 2ое изд. Женева: ВОЗ. 1996. 71 С.
- Дуринян Р. А., Арефьев В. В., Василенко А. М. Разработка опросника для регистрации болевых ощущений и метода их количественной оценки. Анестезиология и реаниматология. 1983: 3—5.
- Ионова Т. И., Новик А. А., Сухонос Ю. А. Качество жизни онкологических больных. Вопросы онкологии. 1998- 44(6): 749−752.
- Ионова Т. И., Новик А. А., Сухонос Ю. А. Понятие качества жизни больных онкологического профиля. Онкология. 2000- 2(1—2): 25−28.
- Ионова Т.И., Рыков И. В., Калядина С. А. Популяция больных гемобластозами гетерогенна по интегральному показателю качества жизни. Вестн. Межнац. центра исследования качества жизни. 2007- 9−10: 99−108.
- Кулаичев А. П., Методы и средства комплексного анализа данных. 4-е изд., перераб. и доп. М.: ФОРУМ: ИНФРА-М. 2006: 387−388.
- Лосева Н. А. Современные методы оценки состояния •онкологических больных, страдающих хронической болью. Паллиативная медицина и реабилитация. 1997- 1: 28−37.
- Новик А. А., Ионова Т. И., Кайнд П. Концепция исследования качества жизни в медицине. Спб.: «Элби».1999. 140 С.
- Новик А. А., Абдулкадыров К. М., Янов Ю. К. и др. Современные подходы к исследованию качества жизни в онкологии и гематологии. Проблемы гематологии и переливания крови. 1999- 2: 45−51.
- Новик А. А., Матвеев С. А., Ионова Т. И. и др. Оценка качества жизни больного в медицине. Клиническая медицина. 2000- 2: 1013.
- Новик А. А., Богданов А. Н. Принципы трансплантации костного мозга и стволовых клеток периферической крови. Спб.: Военно-медицинская академия. 2001. 167 С.
- Новик А. А., Ионова Т. И., Гандек Б. и др. Показатели качества жизни населения Санкт-Петербурга. Проблемы стандартизации в здравоохранении. 2001- 4: 22−31.
- Новик А. А., Ионова Т. И. Руководство по исследованию качества жизни в медицине. М.: ОЛМА, Спб.: Нева, 2002.
- Новик A.A., Ионова Т. И., Киштович A.B. Оценка параметров качества жизни населения Санкт-Петербурга методом интегральных профилей. Вестн. Межнац. центра исследования качества жизни. 2003- 1−2: 28−34.
- Новик А. А., Ионова Т. И., Клиланд Ч. С. и др. Использование краткого опросника слабости (Brief Fatigue Inventory) у больных системными заболеваниями соединительной ткани. Вестн. Межнац. центра исследования качества жизни. 2003- 1−2: 66—71.
- Новик А. А., Ионова Т. И., Калядина С. А. Оценка симптомов у онкологических больных. Вестн. Межнац. центра исследования качества жизни. 2003- 1−2: 79−82.
- Новик А. А., Ионова Т. И. Исследование качества жизни в медицине. Учебное пособие для вузов. Под ред. Ю. Л. Шевченко. М.: ИД «ГЭОТАР-МЕД». 2004. 297 С.
- Новик А. А., Ионова Т. И., Федоренко Д. А. и др. Генерализованная слабость у больных ревматоидным артритом. Вестн. Межнац. центра исследования качества жизни. 2004- 3—4: 29—36.
- Новик А. А., Ионова Т. И., Калядина С. А., Киштович А. В. Профили симптомов у больных с диссеминированными солидными опухолями и гемобластозами. Вестн. Межнац. центра исследования качества жизни: 2006- 7−8: 37−45.
- Новик А. А. От концепции исследования качества жизни к теории принятия решения в клинической.медицине. Вестн. Межнац. центра исследованюгкачества жизни. 2006- 7—8: 20−36.
- Новик А. А., Ионова Т. И. Исследование качества жизни у больных, лимфомами. Вестн. Межнац. центра исследования качества жизни. 2006- 7−8: 121−137.
- Новик А. А., Ионова Т. И. Руководство по исследованию качества жизни в медицине. М.: ОЛМА Медиагруп. 2007. 315 С.
- Новик А. А., Ионова Т. И. Интегральный показатель качества жизни — новая категория в концепции исследования качества жизни . Вестн. Межнац. центра исследования качества жизни. 2006- 7—8: 5—7.
- Новик А. А., Ионова Т. И. Современные стандарты исследования качества жизни в онкологии. Вестн. Межнац. центра исследования качества жизни. 2007- 9−10: 15−25.
- Новик А. А., Ионова Т. И. Руководство по исследованию качества жизни в медицине. 2-е издание. Под ред. академика РАМН Ю. Л. Шевченко М. ЮЛМА Медиа Групп. 2007: 314 С.
- Новик A.A., Ионова Т. И., Киштович A.B. Общий' опросник исследования качества жизни 2-го поколения NJ QoL-29: психометрические свойства инструмента. Вестн. Межнац. центра исследования качества жизни. 2007−9-10: 25−31.
- Новик A.A. О Ионова Т. И., Калядина С. А. Оценка и контроль симптомов в онкологии. Вестн. Межнац. центра исследования качества жизни. 2008- 11−12: 94−107.
- Новик А. А., Ионова Т. И. Исследование качества жизни в онкогематологии. Клиническая онкогематология. 2008- 1(2): 168—173.
- Новик А. А., Ионова Т. И., Иванова В. Л. и др. Рекормон и качество жизни онкологических пациентов с анемией. Вестн. Межнац, центра исследования качества жизни. 2008- 11−12: 77−86.
- Рабочая книга социолога. М.: «Наука». 1976. 307 G.
- Рекомендации- FDA для фармацевтической: индустрии: использование оценок, сделанных пациентом, при внедрении: новой медицинской продукции. Вестн. Межнац. качества жизни. 2006- 7−8: 153— 154. ' '. .. , '
- Сенкевич Hi Ю.,. Белевский A. С. Качество жизни — предмет научных исследований в пульмонологии. Тер. архив. 2000- 3: 36−41.
- Сергиенко В-ТТ, Бондарева-И. Б. Математическая статистика в клинических исследованиях. М.: «Рэотар Медицина" — 2000. 160 С.
- Скоромец Н. М., Чернова Т. В., Елфимов П. В, Бородина 3. И. Результаты анкетирования пациентов врача общей практики. Здравоохранение Российской Федерации. 1997- 3:21−22.
- Социальная сфера Санкт-Петербурга и Ленинградской области. Пегербургкомстат. 1998. 125 С.
- Софронов Г. А., Новик А. А., Ионова Т. И. Концепция исследования качества жизнт в- медицине. Возможности при экспертизе новых лекарственных препаратов. Клинические исследования лекарственных средств в России. 2003- 3−4: 14—17.
- Успенская О.С., Федоренко Д. А., Иванова М. О. и др. Влияние слабости на параметры качества жизни у больных гемобластозами. Вестн. Межнац. центра исследования качества жизни. 2005- 5−6: 47—58.
- Чучалин А.Г., Белевский А. С., Смоленов И. В. и др. Качество жизни больных бронхиальной астмой в России: результаты многоцентрового популяционного исследования. Пульмонология 203- 13 (5):88−96.
- Шевченко Ю. А. Качество жизни в кардиологии. Вестник РВМА. 2000- 9: 5−15.
- Шевченко Ю.Л. Современные подходы к исследованию качества жизни в здравоохранении. Вестн. Межнац. Центра исследования качества жизни. 2003- 1−2: 6−16.
- Шевченко Ю.Л. Концепция исследования качества, жизни в здравоохранении России. Материалы конференции „Исследование качества жизни в медицине“. — Санкт-Петербург. 2000:3—23.
- Шухов В. С. Боль: механизмы формирования, исследование в клинике. Обзорная информация. Медицина и здравоохранение. Серия: Невропатология и психиатрия. 1990- 3: 62 с.
- Aaronson N. К., Bullinger М., Ahmedzai S. A. A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res. 1988- 111: 231−241.
- Aaronson N. K. Quality of life assessment in clinical trials: methodologic issues. Control Clin. Trials. 1989- 10: 195−208.
- Aaronson N. K., Ahmedzai S., Bergman B. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 1993- 85(5): 365−76.
- Adam Z., Pour L., Svobodnik A. Quality of life and tolerance of maintenance therapy in patients with multiple myeloma. Vnitr. Lek. 2002- 48 (3): 216−229.
- Ahles T., Blanchard E., Ruckdeschel J. The multidimensional nature of cancer-related pain. Pain. 1983- 17:277−288.
- Ahles T., Saykin AJ., Furstenberg C.T. et al. Quality of Life of Long-Term Survivors of Breast Cancer and Lymphoma Treated With StandardDose Chemotherapy or Local Therapy. JCO. 2005- 23(19): 4395−4405.
- Ahmedzai S. Current strategies for pain control. Ann. Oncol. 1997- 8(3): 21−24.
- Ahmedzai S. New approaches to Pain Control in patients with cancer. Eur. J. Cancer. 1997- 33(6): S8-S14.
- Aistars J. Fatigue in the cancer patient: A conceptual approach to a clinical problem. Oncol. Nurs. Forum. 1987- 14: 25—30.
- Ancoline-lsrael S., Moore P. The relationship between fatigue and sleep in cancer patients: a review. Eur. J. Cancer Care. 2001- 10: 245−255.
- Andrykowski M., Altmaier E., Barnett R. The quality of life in adult survivors of allogeneic bone marrow transplantation. Transplantation. 1990- 50: 399−406.
- Andrykowski M., Brady M. Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom. Med. 1994- 56: 432−439.
- Andrykowski M., Brady M. „Returning to normal“ following bone marrow transplantation: outcomes, expectations and informed consent. Bone Marrow Transplant. 1995- 15: 573−581.
- Andrykowski M., Curran S., Greiner C. B. et al. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J. Behav. Med. 1998- 21: 1−18.
- Anderson K.O., Giralt S. A, Mendoza T.R. et al. Symptom burden in patients undergoing autologous stem-cell transplantation. BMT. 2007- 3: 759 766.
- ASCO. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncology. 1996- 14(3): 671—679.
- Aviles A., Duque G., Talavera A et al. interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival// Leuk lymphoma 1996−20: 495−499.
- Bacon C. G., Giovannucci E., Testa M. et al. The association of treatment-related symptoms with quality of-life outcomes for localized prostate carcinoma patients. Cancer. 2002- 94(3): 862−871.
- Baker F., Zabora J., Polland A. et al. Reintegration after bone marrow transplantation. Cancer Pract. 1997- 48: 190−197.
- Bertero C., Eriksson B.E., Ek A.C. Explaining different profiles in quality of life experiences in acute and chronic leukemia. Cancer Nurs. 1997- 20 (2): 100−104.
- Bietz J., Gnecco C., Justice R. Quality of life endpoints in cancer clinical trials: the US Food and drug Administration perspective. J. Natl. Cancer Inst. Monogr. 1996- 20: 7−9.
- Bloom J. R. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J. clin. Oncol. 1998- 25(1): 3— 8.
- Bonica J.J. Treatment in cancer pain: current status and future needs. Eds. H. L. Fields, R. Dubner, F. Cervero. Proceedings of the Fourth World Congress on Pain. Vol. 9 of Advances in pain research and therapy. New York: Raven Press. 1985: 589−616.
- Bonomi A. E., Cella D. F., Hahn E. A. et al. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) Quality of Life Measurement System. Qual. Life Res. 1996- 5: 1−12.
- Bostrom B., Sandh M., Lundberg D., Fridlund B. A comparison of pain and health-related quality of life between two groups of cancer patients with differing average levels of pain. J. Clinic. Nurs. 2003- 12: 726−735.
- Bottomley A., Neil K. Aaronson International Perspective on Health-Related Quality-of-Life Research in Cancer Clinical Trials: The
- European Organisation for Research and Treatment of Cancer Experience. J. clin. Oncol. 2007- vol.25, № 32 (November 10): 5082−5086.
- Bowling A. Measuring Disease: a review of disease-specific quality of life measurement scales. Open University Press: Philadelphia. 1996. 374 p.
- Bowling A. Measuring Health: a review of quality of life measurement scales. 2-nd edition. Open University Press: Philadelphia. 1997. 160 P
- Bowling A., Ebrahim S. Handbook of health research methods. Maidenhead: Open University Press.2005.
- Broers S., Kaptein A. A., Le Cessie S. et al. Psychological functioning and quality of life following bone marrow transplantation: a 3—year follow-up study. J. Psychosom. Res. 2000- 48: 11−21.
- Bloom J.R. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J Clin Oncol. 1993- 11 (5): 979−988.
- Bruera E., Kuehn N., Miller M. J. et al. The Edmonton Symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J. Palliat. Care. 1991- 7: 6−9.
- Buhle L., Carroll D., Seers K. Relaxation for the relief of chronic pain: a systematic review. J. Adv. Nurs. 1998- 27: 476−487.
- Bullinger M., Anderson R., Cella D. et al. Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Qual. Life Res. 1993- 2: 451−459.
- Bullinger M., Power M.J., Aaronson N.K. et al. Creating and evaluating cross-cultural Instruments. Quality of life and pharmacoeconomics in clinical trials. 2nd edition. Philadelphia: Lippincott-Raven Publishers. 1996: 659 668.
- BuLLinger M., Alonso J., Apolone G. et al. Translating health status questionnaires and evaluating their quality: The International Quality of Life Assessment Project approach. J. Clin. Epidemiol. 1998- 51(11): 913—923.
- Burge P. S., Prankerd T. A., Richards J. D. et al. Quality and quantity of survival in acute myeloid leukaemia. Lancet. 1975- 2:865—70.
- Campbell D., Fiske D. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin. 1993- 2: 451−459.
- Caraceni A., Cherny N., Fainsinger R. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European association of Palliative Care. J. Pain Symptom Manage. 2002- 23(3): 233−255.
- Carol M. Funding Patient-Reported Outcomes in Cancer Clinical Trials. J. clin. Oncol. 2007- 10: 5100−5105.
- Carlsson A. M. Assessment of chronic pain: I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983- 16: 87—101.
- Cella D., Tulsky D. Measuring quality of life today: methodological aspects. Oncology. 1990- 944(5): 29−38.
- Cella D. Manual: Functional Assessment of Cancer Therapy (FACT). NY.: Scales.1992.
- Cella D., Lai J. S., Chang C. H. et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002- 94: 528−538.
- Cella D., Dobrez D., Glaspy J. Control of cancer related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Annals of Oncology. 2003- 14: 511−519.
- Chang V. T., Thaler H. T., Polyak T. A. et al. Quality of life and survival: The role of multidimensional symptom assessment. Cancer. 1998- 83: 173−179.
- Chang V. T., Hwang S. S., Feuerman M. et al. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer. 2000- 88(5): 1175−1183.
- Chao N. J., Tierney D. K., Bloom J. R. et al Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood. 1992- 80: 825−830.
- Chen M. L., Chang H. K., Yeh C. H. Anxiety and depression in Taiwanese cancer patients with and without pain. J. Adv. Nurs. 2000- 32(4): 944— 951.
- Cherny N. Cancer pain: principles of assessment and syndromes. Principles and practice of supportive oncology- Eds. A. M. Berger, R. K. Portenoy, D. E. Weissman. NY.: Lippincott-Raven. 1998: 3—34.
- Chapman C. R., Casey K. L., Dubner R. et al. Pain measurement: An overview. Pain. 1985- 22(1): 17−25.
- Cleeland C. S. The impact of pain on the patient with cancer. Cancer. 1984- 58: 2635−2641.
- Cleeland C. S., Cleeland L. M., Dar R. et al. Factors influencing physician management of cancer pain. Cancer. 1986- 58: 796−800.
- Cleeland C. S. Measurement of pain by subjective report. Eds. C. R. Chapman, J. D. Loeser. Issues in pain measurement. Vol. 12 of Advances in pain research and therapy. NY.: Raven Press. 1989: 391403.
- Cleeland C. S. Pain assessment in cancer. Ed. Osoba D. Effect of cancer on quality of life. Boca Raton, Fia.: CRC Press. 1991: 293−305.
- Cleeland C. S. Research in cancer pain: what we know and what we need to know. Cancer. 1991- 67: 823−827.
- Cleeland C. S., Syrjala K. L. How to assess cancer pain. Eds. D. Turk, R. Melzack. Pain assessment. NY: Guilford Press. 1992: 360−387.
- Cleeland C. S. Documenting Barriers to Cancer Pain Management. Eds. C. R. Chapman, K. Foley. Current and emerging issues in cancer pain: research and practice. NY.: Lippincott-Raven. 1993: 150−162.
- Cleeland C. S., Gonin R., Hatfield A. Pain and its treatment in outpatients with metastatic cancer. New Eng. J. of Medicine. 1994- 330: 592−596.
- Cleeland C., Ryan K. Pain assessment: global use of the brief pain inventory. Ann. Acad. Med. Singapore. 1994- 23(2): 129−138.
- Cleeland C., Nakamura Y., Mendoza T. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996- 67: 267−273.
- Cleeland C., Wang X. Measuring and» Understanding Fatigue. Oncology. 1999- 13 (11A): 91−97.
- Close D. R., A. Olivarez Jr. Measurement of health-related quality of life:.reliability and validity of the SF—36 health survey in patients with cancer. Qual. Life Res. 2000- 9(3): 296.
- Coates A. S., Gebski V., Signorini D. et al: Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J. Clin. Oncol. 1992- 10: 1833−1838.
- Coates A. S., Porzsolt F., Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur. J. Cancer. 1997- 33: 1025−1030.
- Coyle N., Adelhardt J., Foley K. M. et al. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life. J. Pain Symptom Manage. 1990- 5: 83−93.
- Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrics. 1951- 16(3): 297−334.
- Curran D., Fayers P., Molenberghs G., Machin D. Analysis of incomplete quality of life data in clinical trials. Quality of Life Assessment in
- Clinical! Trials. Ed. M J. S taquet. Oxford University Press: Oxford- New York, Tokyo. 1998: 249−280.
- Curt G. A. The impact of fatigue, on patients with cancer. The Oncologist, 2000- 5(2): 9−12.
- Dancey J., Zee B., Osoba D. Quality of life scores: an independent prognostic variable in- a general' population of cancer patients receiving chemotherapy. Can. Med. Assoc. J. 1996- 10: 225−230.
- Daut R. L., Cleeland C. S. The prevalence and severity of pain in cancer. Cancer. 1982- 50: 1913−1918.
- Derogatis L. R., Morrow G. R., Fetting J. el al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983- 249: 751—757.
- Dimeo F., Bertz H., Lepage E. et al. An aerobic exercise program for. patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant. 1996- 18: 1157−1160.
- Dimeo F., Fetscher S., Mertelsmann R. et al. Effects of aerobic exercise on the physical- performance and incidence of treatment-related complications after high dose chemotherapy. Blood. 1997- 90: 3390−3394.
- Dodd M. J., Miaskowski C., Paul S. Symptom clusters and their effect on the functional status of patients with cancer. Oncol. Nurs. Forum. 2001- 28: 465−470.
- Dodd MJ, Miaskowski C., Lee KA. Occurrence of symptom clusters. J Nation Cancer Institute Monographs. 2004- 32: 76−78.
- Donnelly S., Walsh D. The symptoms of advanced cancer. Semin. Oncol. 1995- 22(3): 67−72.
- Dumontt C., Bastion Y., Felman P. et al. Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen. Ann. Oncol. 1992- 3: 639−644.
- Dysvik E., Lindstrom T. C., Eikeland O. J. et al. Health-related quality of life and pain beliefs among people suffering from chronic pain. Pain Manag. Nurs. 2004- 5(2): 66−74.
- Duvic M., Hymes K., Heald P. et al. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. Psychol. Med 1983- 13: 55−605.
- Edwin P. Rock. Patient-Reported Outcomes Supporting Anticancer Product Approvals. J. clin. Oncol. 2007- 10(November): 5094−5099.
- Efficace F., Novik A., Vignetti M. et al. Health-related quality of life and symptom assessment in clinical research of patients with haematological malignancies: where are we now and where do we go from here? Haematologica 92(12): 1596−1598,2007.
- Erickson P. Modeling health-related quality of life: The bridge between psychometric and utility-based measures. J. of the National Cancer Institute. 1996- Monograph 20: 17−22.
- Escalante C., Martin C. G., Elting L. S. et al. Dyspnea in cancer patients. Etiology, resource utilization, and survival—implications in a managed care world. Cancer. 1996- 78: 1314−1319.
- Escalante C., Grover T. A Fatigue clinic in a comprehensive cancer center. Cancer. 2001- 92(6): 1708−1713.
- ESIvTO policy on supportive and palliative care. Appendix 2. In: Catane R, Cherny N1, Kloke M et al. Handbook of advanced cancer care. Taylor&Fracis. London and NewYork. 2006.
- Evans D. R., Thompson A. B., Browne G. B. Factors associated with the psychological well-being of adults with acute leukemia in remission. J. Clin. Psychol. 1993- 49: 153−160.
- Fairclough D. Method of analysis for longitudinal studies of health—related quality of life. Quality of Life Assessment in Clinical Trials. Oxford University Press: Oxford, New York, Tokyo. 1998: 227−247.
- Fairclough D. L. Patient reported outcomes as endpoints in medical research. Stat. Methods Med. Res. 2004- 13: 115−38.
- Fauser A. A., Fellhauer M., Hoffmann M. et al. Guidelines for antiemetic therapy: Acute emesis. Eur. J. Cancer. 1999- 35: 361—370.
- Fayers P., Aaronson N., Bjordal K., Sullivan M. QLQ C-30 Scoring Manual. EORTC Study Group on Quality of Life. Brussels. 1995. 50 P.
- Fayers PM, Machin D. Quality of Life Assessment, Analysis and Interpretation. Chichester: John Wiley, 2-nd edition. 2007.
- Fayers P., Hays R. Assessing Quality of Life in Clinical Trials: Methods and Practice. Oxford University Press: Oxford, New York. 2005.
- Fernsler J., Fanuele J.S. Lymphomas: long-term sequelae and survivorship issues. Semin Oncol Nurs. 1998- 14 (4):321—328.
- Ferraz M. Cross cultural adaptation of questionnaires: what is it and when should it be performed? J. Rheumatol. 1997- 27(12): 2066−2068.
- Ferrario E., Ferrari L., Bidoli P. et al. Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treatment, 2004.
- Ferrell B., Grant M., Padilla G. et al. The experience of pain and perceptions of quality of life: validation of a conceptual model. Hosp. J. 1991- 7: 9−24.
- Fink R., Gates R. Pain assessment. Eds. B.R. Ferrell, N. Coyle. Oxford: Oxford University Press. 2001: 53—71.
- Flechtner H., Bottomley A. Fatigue and quality of life: lessons from the real world. Oncologist. 2003- 8(1): 5−9.
- Foley K. Assessment of pain in patients with cancer. Cancer pain. Eds. M. Swerdlon, V. Ventafridda: NY: Lippincott-Raven. 1987: 374.
- Foley K. M. Pain assessment and cancer pain syndromes. Oxford Textbook of Palliative Medicine- Eds. D. Doyl, G. C. Hanks, N. McDonald. Oxford: Oxford’University Press. 1993: 148−165.
- Freishman S. B. Treatment of Symptom Clusters: Pain, Depression and Fatique. J. Natl. Cancer Monogr. 2004- 32: 119−123.
- Gandek B., Ware J. Methods for validating and norming translations of health status questionnaires: The IQOLA Project approach. J. Clin. Epidemiol. 1998- 51(11): 953−959.
- Ganz P. A., Lee J. J., Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer. 1991- 67: 3131−3136.
- Ganz P. A., Carolyn C. Gotay Use of Patient-Reported Outcomes in Phase III Cancer Treatment Trials: Lessons Learned and Future Directions. J. clin. Oncology. 2007- vol. 25, No 32 (November 10): 5063−5069.
- Girling J. G., Hopwood P., Ahmedzai S. Assessing quality of life in palliative oncology. Progress in Palliative Care. 1994- 2: 80−86.
- Glise H, Hallerback B, Wiklund I. Quality of Life: a reflection of symptoms and concerns. Scand. J. Gastroenterol. 1996- 221: 14- 17.
- Goisis A., Gorini M., Ratti R. et al. Application of a WHO protocol on medical therapy for oncologic pain in internal medicine hospital.Tumori. 1989- 75: 470172.
- Gondek K., Sagnier P.-Ph., Gilchrist K., Woolley J. M. Current Status of Patient-Reported Outcomes in Industry—Sponsored Oncology Clinical Trials and Product Labels. J. clin. Oncol. 2007- vol.25, № 32 (November 10): 5087−5093.
- Gordon L.I., Witzig T.E., Wiseman G.A. et al. Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed' or refractory low-grade non-Hodgkin's lymphoma. Semin. Oncol. 2002- 29: 87−92.
- Grandjean E. Fatigue: its physiological and psychological significance. Ergonomics. 1968- 11:427−436.
- Greenwald H. P., Bonica J. J., Bergner M. The prevalence of pain in four cancers. Cancer. 1987- 60: 2563−2569.
- Grond S., Zech D., Diefenbach C. et al. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic. J. Pain Symptom Manage. 1994- 9: 372—382.
- Grond S., Zech D., Diefenbach C. et al. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996- 64: 107−114.
- Guha-Thakurta N., Damek D., Pollack C. et al. Intravenous methotrexate as initial treatment for primary central nervous system lymphoma response to therapy and quality of life of patients. J. Neurooncol. 1999- 43: 259 268.
- Hadhorn D., Hays R. Multitrait-multimethod analysis of health related quality of life preferences. Med. Care. 1991- 29: 829−840.
- Hann D.M., Jacobsen P.B., Martin S. C et al. Quality of Life following bone marrow transplantation for breast cancer: a comparative study. BMT. 1997- 19: 257−264.
- Gorodokin G., Novik A. Quality of cancer care. Ann Oncol. 2005- 16(6): 991.
- Guillemin F., Bombardier C., Beaton D. Cross—cultural adaptation of health related quality of life measures: literature review and proposed guidelines. J. Clin. Epidemiol. 1993- 46(12): 1417−1432.
- Hayabuchi N., Jingu K., Miyoshi M. et al. Radiotherapy and chemotherapy in stage I and II non-Hodgkin's lymphomas of Waldeyer’s ring. J. Jpn.Soc. Cancer Ther. 1990- 25: 1428−1436.
- Hays R. D., Sherbourne C. D., Mazel R. M. User’s Manual for Medical Outcomes Study (MOS) Core measures of health-related quality of life. RAND Corporation, MR-162-RC (available at www.rand.org).
- Hermans J., Krol A.D.G., van Groningen K., et al. International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood. 1995- 86: 1460−1463.
- Hetzel-Sesterheim M., Schnabel K., Nestle U. Primary cerebral non-Hodgkin's lymphomas. The results of radiotherapy. Leukemia. 1996- 10(4): 707−712.
- Hjemstad M. J., Evensen S. A, Kvaloy S. O. et al. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J. Clin. Oncol. 1999- 17: 706−718.
- Hjemstad M. J., Loge J. H. et al. The course of anxiety and depression during fist year after allogeneic or autologous stem cell transplantation. J. Bone marrow transplant. 1999: 1219−1228.
- Hjemstad M. J., Fossa S., Oldervold L. et al. Fatigue in Long-Term Hodgkin’s Disease Survivors: A Follow-Up Study. JClin Oncology. 2005−23(27): 6587−6595.
- Hoerni B. Quality of life during and following radiochemotherapy for Hodgkin’s disease. Evaluation of 60 patients. Bull. Cancer. 1983- 70(4): 284— 288.
- Hosmer D. W. Jr., Lemeshow S. Applied logistic regression. New York: John Wiley. 1989: 106−118.
- Hornquist I. Quality of life: concept and assessment. Scand. J. Social. Med. 1982- 10: 57−61.
- Hwang S. S., Scott C. B., Chang V. T. et al. Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress. Cancer Invest. 2004- 22: 678−687.
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993- 329: 987−994.
- Ionova T. I., Novik A. A., Kishtovich A. V. et al. Fatigue and quality of life (QoL) impairment in advanced cancer. Clinic. Oncol. 2005- 23(16): 780.
- Irvine D., Vincent L., Bubela N. et al. Fatigue experienced by healthy individuals. Cancer Nurs. 1994- 17: 367−378.
- Jerkeman M., Anderson I I., Cavallin-Stahl E. et al. CHOP versus MACOP-B- in aggressive lymphoma a Nordic Lymphoma Group, randomized trial. Ann. Oncol. 1999- 10: 1079−1086.
- Jerkeman M, Kaasa S., Hjermstad M. et al. Health-related quality of life and its potential prognostic implications in patients with aggressivelymphoma: a Nordic Lymphoma Group Trial. Med Oncol. 2001- 18(1): 85−94.
- Johnson J. R., Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Reports. 1985- 69: 1155−1157.
- Joly F. Late psychosocial sequelae in Hodgkin’s disease survivors: a Franch population-based case-control study. J: clin. Oncol. 1996- 14(9): 24 442 453.
- Kaasa S., Mastekaasa A., Lund E. Prognostic factors for patients with, inoperable non small lung cancer, limited- disease. The importance ofpatients' subjective experience of disease and psychosocial well-being. Radiother. Oncol. 1989- 15:235−242.
- Kaasa S., Loge J. H., Knobel H. et al.Fatigue. Measures and relation to pain. Acta Anaesthesiologica Scandinavica. 1999- 43(9): 939.
- Kalyadina S.A., Ionova T.I., Ivanova M. O. Russian Brief Pain Inventory: Validation and Application in Cancer Pain. Journal of Pain and Symptom Management. 2008- 35(1): 95−102.
- Kind P. The EuroQoL Instrument: an index of health —related quality of life. Quality of life and pharmacoeconomics in clinical trials. Ed. Spilker B. 2nd Edition. Philadelphia: NY.: Lippincott-Raven. 1996: 191−201.
- Kirkova J, Davis M, Walsh D et al. Cancer Symptom Assessment Instruments: A Systematic Review. Journal of Clinical Oncology. 2006- 24 (9): 1459−1473.
- Knobel H., Loge J. H., Nordoy T. et al. High level of fatigue in lymphoma patients treated with high dose therapy. J. Pain Symptom Manage. 2000- 19: 446−456.
- Kornblith A. B. Quality of life assessment of Hodgkin’s disease survivors: a model for cooperative clinical trials. Oncology. 1990- 4(5): 93—101.
- Lee V. C., Rowlingson J. C. Defining Quality of Life in Chronic Pain. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed- Ed. B. Spilker. Philadelphia: Lippincott-Raven Publishers. 1996: 853−864.
- Lerue A. R. Multicentre study of cancer pain and its treatment in France. British J. General Practice. 1995- 310: 1034−1037.
- Leventhal H. Affect, cognition, and symptom perception. Eds. C.R. Chapman, K. Foley. Current and emerging issues in cancer pain: research and practice. NY.: Lippincott-Raven. 1993: 540—563.
- Littlewood T. J., Cella D., Nortier J. WR. Erythropoetin improves quality of life. The Lancet Oncology. 2002- 3(8): 235−239.
- Lopez-Guillermo A., Montserrat E., Bosch F. et al. Applicability of the International Prognostic Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol. 1994- 12: 1343−1348.
- Mainpour C. M. Quality of life end points in cancer clinical trials. National Cancer Institute. 1989- 81: 485−495.
- McCorkle R. The measurement of symptom distress. Semin. Oncol. Nurs. 1987- 3: 248−256.
- McGuire D. B. Occurrence of cancer pain. J. Natl. Cancer Inst. Monogr. 2004- 32:51−56.
- McQuellon R. R., Craven B., Russell G. B. el al. Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant. 1996- 18: 579−584.
- McQuellon R. R., Russell G. B., RamboT. D. Quality of life psychological distress of bone marrow transplant recipients: the «time trajectory» to recovery over the first year. Bone Marrow Transplant. 1998- 21: 477−486.
- Mehta C. R., Patel N. R. A network algorithm for performing Fisher’s exact test in r x c contingency tables.J. Am. Stat. Assoc. 1983- 78: 427— 434.
- Melzak R., Katz J. The McGill Pain Questionnaire: appraisal and current status. Eds. D.C. Turk, R. Melzak. Handbook of pain assessment. NY.: Guilford Press. 1992: 152−168.
- Mendoza T. R., Wang X. Cleeland C. S. et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999- 85(5): 1186−1196.214. ' '
- Mercadante S., Casuccio A., Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J. Pain Symptom Manage. 2000- 20(2):T04−112.
- Mercadante S., Girelli D., Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Support. Care Canccr. 2004- 12(5): 355−359.
- Moinpour C., Chapman C., Georgiadou F. Cancer pain and quality of life. Eds. C.R. Chapman, K. Foley. Current and emerging issues in cancer pain: research and practice. NY.: Lippincott-Raven. 1993: 564— 583.
- Molassiotis A., Morris P J. Quality of life in patients-with chronic myelogenous leukemia after unrelated donor bone marrow transplantation. Cancer Nurs. 1999- 22 (5): 340−349.
- Molica S. Quality of life in chronic lymphocytic leukemia: a neglected issue. Eeuc. Lymphoma. 2005- 46: 1709−14.
- Moskowitz C. H. An update on the management of relapsed and refractory Hodgkin’s Lymphoma. Seminars in Oncology. 2004- 31:54—59.
- Moskowitz C. H. Outcome of patients with primary refractory HD treated with high dose combined modality therapy and ASCT. British Journal of Haematology. 2004- 124: 645−652.
- Morris A., Perez D., McNoe B. The use of quality of life data in-clinical practice. Qual: Life Res. 1998- 7: 85−91.240- Morrison D. F. Multivariate statistical methods. D. F. Morrison 3rd ed: New York: McGraw-Hill. 1990: 164−170.
- Mystakidou K., Parpa .E., Katsouda E. et al. Influence of pain and, quality of life on desire for hastened death in patients with advanced cancer. Int. J. Palliat. Nurs. 2004- 10(10): 476−483.
- Nail.L., Winningham M. Fatigue and weakness in cancer patients: thesymptoms experience. Semin. Oncol. Nurs. 1995- 11: 272—278.
- NGCN Cancer-related Fatigue Panel: National Comprehensive: Cancer Network: Clinical Practice Guidelines in Oncology. Cancer-related-fatigue:. Version 1, 2006 www.nccn.org.. v. r :
- NCCN Distress Management Panel: National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Distress Management Version 1, 2005 www.nccn.org.
- Nelson D., Novy M. Self-report differentiation of anxiety and depression in chronic pain. J. Personal Ass. 1997- 69(2): 392−407.
- Niscola P., Arcuri E., Giovannini M. et al. Pain- syndromes in haematological malignancies: an overview. Hematol. J. 2004- 5(4): 293−303.
- Ng A.K., Henry-Amar M. Assessing quality of life in patients with lymphoma. In: Mauch PM, Armitage JO, Coiffier B, Dalla-Favera R, Harris NL, eds. Non-Hodgkin's Lymphomas. Lippincott Williams & Wilkins, Philadelphia. 2004: 561−571.
- Norum J. Quality of life in survivors of Hodgkin’s disease. Qual. Life-Res. 2000 — 61(3): 367−374.
- Novik A. A., Ionova T. I., Maximov A. G., Kovalenko A. N. Factors influencing quality of life in Non-Hodgkin's lymphoma patients after conventional chemotherapy. Ann. Oncol. 1999- 10(3): 181.
- Novik A., Ionova T., Povzun A., Maximov A. Fatigue as the most sensitive EORTC QLQ-C30 scale in lymphoma patients. Qual. Life Res. 1999- 8(7): 642.
- Novik A. A., Ionova T. I., Povzun A. S. et al. Early impact of chemotherapy on quality of life of malignant lymphoma patients. Ann. Oncol. 2000- 23(3): 182.
- Novik A. A., Ionova T. I., Povzun A. S. et al. Quality of life of in patients with different types of leukemia. Qual. Life Res. 2000- 9(3): 294.
- Novik A. A., Ionova T. I., Tzepkova A. A. et al. Quality of life of the population of St. Petersburg. Qual. Life Res. 2000- 9(3): 308.
- Novik A. A., Manikhas G.M., Ionova T.I. et al. Comparison of symptom severity and prevalence between hematological malignancies and solid tumors among Russian oncology patients. Blood. 2002- 100(1): 387.
- Novik A. A., Ionova T. I., Kishtovich A. V. et al. Model of symptom interference with quality of life in advanced cancer patients. Qual. Life Res. 2005- 14(9): 2101.
- Novik A., Ionova T., Kishtovich A. Heterogeneity of new lymphoma patients in terms of quality of life parameters Blood. 2003- 22: 302.
- Nunnaly J. C., Bernstein I. R. Psychometric Theory. 3-th Edition. New-York. 1994: 243.
- O’Brien B., Rusthoven J., Tormey D. C. et al. Impact of chemotherapy—associated nausea and vomiting on patients' functional status and costs. Can. Med. Assoc. J. 1993- 149: 296−302.
- Osby E. Quality of life and care in leukemia, myeloma and non-malignant disease. Opinions of patients and relatives, and effects of geography and time. Med Oncol Tumor Pharmacother. 1989- 6 (2): 133−141.
- Osoba D. Lessons learned from measuring health-related quality of life in oncology. J. clin. Oncol. 1994- 12- 608−616.
- Peteet J., Tay V., Cohen G. et al. Pain characteristics and treatment inan outpatient cancer population: Cancer:. 1986- 57: — 1259—, 1265-
- Pirovano M, Maltoni M., Nanni O. et al. A New. Palliative- Prognostic Score A First Step for the Staging- of Terminally 111- Cancer Patients. J. Pain Symptom Manage. 2005- 29(3):.224−237.
- Piotrowski C. Assessment of pain: a survey of practicing clinicians. Percept Mot Skills. 1998- 86(1): 181−182.2681 Portenoy R. K. Cancer pain: epidemiology and syndromes. Cancer. 1989- 63: 2298−2307.
- Portenoy R. K., Thaler H. T., Kornblith A. B. et al. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress .Eur. J. Cancer. 1994- 30A: 1326— 1336.
- Poulos A. R., Gertz M. A., Pankratz V. S. et al. Pain, mood disturbance, and quality of life in patients with multiple myeloma- Oncol. Nurs. Forum. 2001- 28(7): 1163−1171.
- Quality of life and pharmacoeconomics in clinical trials-- Ed. Spilker B- 2nd Edition. Philadelphia: New-York Eippincott-Raven. 1996.218
- Quality of life assessment in clinical- trials. Ed. B. Spilker. New York. 1990.2731 Quality of life assessment in clinical trials. Ed. M. J. Staquet, R. Hays, P.Fayers. Oxford University Press: Oxford, New York, Tokyo. 1998.
- Rock E. P., Kennedy D. L., Furness Mi H. et al. Patient-Reported Outcomes Supporting Anticancer Product Approvals. J. Clin. Oncol. 2007- 25 (32): 5094−5099:
- Schumacher A., Wewers D, Heinecke A. Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia: Leuk. Res. 2002- 26(4): 355−362. ¦: .
- Serlin R. S., Mendoza T. R., Nakamura Y. et al. When is cancer pain mild, moderate or severe? Graiding pain severity by its interference with function. Pain. 1995- 61: 277−284.
- Stalfelt A. M., Brodin H., Pettersson S., Eklof A. The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain. Leuk. Res. 2003- 27: 481−488.
- Steven B. Clauser et al. Patient—Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making. J. clin. Oncol. 2007- 10(November): 5049−5050.
- Stone P., Hardy J., Broadley K. et al. Fatigue in advanced cancer: A prospective controlled cross-sectional study. Br. J. Cancer. 1999- 79: 14 791 486.
- Sullivan K. M. Long-term follow-up and quality of life after hematopoietic stem cell transplantation. J. Rheumatology. 1997- 24(48): 46 — 52.
- Tannock I. F. Treating the patient, not just the cancer. N. Engl. J. Med. 1987- 317: 1534−1535.
- Teoh N., Stjernsward N. WHO cancer pain relief program ten years on. Seattle: International Assosiation for the Study of Pain. LASP Newsletter. 1992: 5- 6.
- Tishelman C., Taube A., Sachs L. Self—reported symptom distress in cancer patients: Reflections of disease, illness or sickness? J. Pain Symptom Manage. 2005- 29(2): 165−172.
- Uematsu M., Kondo M., Hiramatsu H. Stage IA Non-Hogdkin's lymphoma of the Waldeyer’s ring. Acta Oncologica. 1993- 32(6): 675— 678.
- Vainio A., Auvinen A. Prevalence of symptoms among patient with advanced cancer: an international collaborative study. J. Pain Symp. Manage. 1996- 12: 3−10.
- Van Tulder M. W. The quality of life of long-term survivors of Hodgkin’s disease. Semin. Hematol. 1997- 34(2): 4−12.
- Vigano A., Donaldson L., Higginson I. et al. Quality of Life and Survival Prediction in Terminal Cancer. A Multicenter Study. CANCER. Published Online: July 26. 2004.
- Vuorinen E. Pain as an early symptom in cancer. Clin. J. Pain. 1993- 9: 272−278.
- Walsh D., Donnelly S., Rybicki L. The Symptoms of Advanced Cancer: Relationship to Age, Gender, and Performance Status in 1,000 Patients. Support. Care Cancer. 2000- 8(3): 0175−0179.
- Wallwork L., Richarson A. Beyond cancer: changes, problems and needs expressed by adult lymphoma survivors attending an out patients clinic. Eur J Cancer Care (Engl) 1994−13−3:122−132.
- Wang X. S., Cleeland C. S., Mendoza T. R. et al. The effect of pain severity on health-related quality of life. Cancer. 1999- 86(9): 1847−1855.
- Wang S., Giralt S., Mendoza T. et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J. Clin. Oncol. 2002- 20:1319−1328.
- Wang S.X., Girolli S.A., Mendoza T.R. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and Non-Hodgkin lymphomas. Journal of Clinical Oncology. 2002- 20 (5): 1319−1328.
- Wang SX, Cleeland CS, Williams L. Longitudinal assessment of inflammatory cytokines and symptom severity during 100 days of allogenic BMT for AML/MDS patients. Blood. 2005- 106: abstract#4569.
- Ware J., Gandek B. Methods for testing data quality, scaling assumptions, and reliability: The IQOLA Project approach. J. Clin. Epidemiol. 1998- 51(11): 945−952.
- Ware J. E. Standards for validating health measures: Definition and content. J. Chronic Diseases. 1987- 40: 473-^80.
- Ware J. E., Sherbourne C. D. The MOS 36-item short form health survey (SF—36): conceptual framework and item selection. Medical Care. 1992- 30: 473-^83.
- Ware J. E., Snow К. K., Kosinski M. et al. SF-36 health survey: Manual and Interpretation guide. MA: Boston. 1993: 143 P.
- Ware J. E. The status of health assessment 1994. Public Health. 1995- 16:327−354.
- Ware J., Kosinski M., Gandek B. et al. The factor structure of the SF-36 health survey in 10 countries: results from the IQOLA Project. J.Clin. Epidemiol. 1998- 51(11): 1159−1165.
- Watkins B. D. Issues and Challenges With Integrating Patient-Reported Outcomes in Clinical Trials Supported by the National Cancer Institute-Sponsored Clinical Trials Networks. J. clin. Oncol. 2007- 10: 5051−5057.
- Watkins B. D. Should Patient-Reported Outcomes Be Mandatory for Toxicity Reporting in. Cancer Clinical Trials? J. Clin. Oncol. 2007- 1: 5345— 5347.
- Webster K., Cella D. Quality of life in patients with low-grade Non-Hodgkin's lymphoma. Onclogy, 1998. V. 12. N5 pp.697−714.
- Whedon M., Stearns D., Mills L. E. Quality of life of long-term adult survivors of autologous bone marrow transplantation. Oncology Nursing Forum. 1995- 22(10): 1527−1535.
- Williams L. A., Wang S., Cleeland C. S., Mobley G. Assessment of Symptoms and Symptom Burden before and after Engraftment during Allogeneic Blood or Marrow Transplant (BMT). Session Type: Poster Session 481−1. Blood. 2005- 106(11): 1323.
- Williams G. H. Assessing patients wellness: new perspectives on quality of life and compliance. AJH. 1998- 11(11−12): 186−191.
- Winningham M. L., Nail L. M., Burke M. B. et al. Fatigue and the cancer experience: the state of the knowledge. Oncology Nursing Forum. 1994- 21(1): 23−36.
- Wisloff F., Hjorth M. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. Br. J. Haematol. 1997- 97: 29 37.
- Wisloff F., Hell strom—Lindberg E. et al. A validated decision model for treating the anemia of myelodysplastic syndromes with erythropoietin and G-CSF — significant effects on quality of life. Br. JLHaematology. 2003- 120: 1037−1046.
- Wisloff F., Gulbrandsen N., Hjorth M. Quality of life may be affected’more by disease parameters and response to therapy than by haemoglobin-changes. Eur J Haematol. 2005−75(4):293−8.
- World Health Organisation. Cancer Pain Relief and Palliative Care. 2nd ed. Geneva. World Health Organisation. 1990.
- World Health Organisation. Cancer Pain Relief with a Guide to Opioid Availability. Ed 2. Geneve. 1996.
- Yellen S. B., Cella D. F., Bolomi A. Quality of life in people with Hodgkin’s disease. Oncology. 1993- 7: 41.
- Yellen S. B., Cella D. F. Measuring Fatigue and other anemia-related symptoms with the Functional Assesment of Cancer Therapy (FACT) measurement system. J. Pain Symptom Manage. 1997- 13(2): 63—74.
- Zar J: H. Biostatistical analysis. 2nd ed. Englewood Cliffs. N.J.: Prentice-Hall. 1984.
- Zech D. F., Grond S., Lynch J. et al Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995- 63(1): 65−76.